National LTC Pharmacy Advocacy Group Praises Grassley, Wyden Call for PBM “Spread Pricing” Probe
Washington, DC –The Senior Care Pharmacy Coalition (SCPC) today praised Senate Finance Committee Chairman Charles Grassley (R-IA) and Ranking Member Ron Wyden (D-OR) for asking the U.S. Department of Health and Human Services (HHS) to probe the controversial pharmacy benefit manager (PBM) practice of “spread pricing” whereby PBMs charge one amount to health plans for a drug, then reimburse pharmacies a lower amount — and pocket the difference.
“We’re pleased by the activist investigatory approach taken by Senators Grassley and Wyden,” said Alan G. Rosenbloom, President of SCPC, the only federal advocacy organization devoted exclusively to the interests of the nation’s LTC pharmacies and the patients they serve. “When it comes to addressing the tangled web of opaque drug pricing transactions that undermine consumers, taxpayers and America’s health care system at-large, spread pricing is a ripe target for investigation.”
Rosenbloom pointed out that Bloomberg News has previously reported that PBMs have taken large markups in Medicaid plans. For many commonly prescribed generic medications, state insurance plans are paying millions in fees to PBMs, Bloomberg’s analysis found.
The SCPC leader lauded the efforts of Ohio Attorney General Dave Yost in seeking repayment of millions in public funds related to PBM OptumRx’s deceptive administration of the state’s Medicaid managed care program. Yost suggested to Bloomberg the complexity of the pricing practices and the system itself in this Ohio instance is designed to deceive: “I am concerned that it is internally complex and that it may be for the purposes of deception.”
Rosenbloom said that while sweeping reforms along the entire prescription drug supply chain are an SCPC priority, he warned the Senate Finance Committee yesterday that significant PBM financial losses that may occur in the aftermath of reform must not be “cost-shifted” to LTC pharmacies. He detailed four drug pricing reform policy recommendations to help ensure this does not occur.
####
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
SCPC Calls for Immediate Congressional Action to Fix Broken LTC Pharmacy Payment Model as More Drugs Become Subject to Mandatory Medicare Price Negotiations
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
SCPC Praises FTC for Report Highlighting Egregious PBM Abuses; Encourages Congress and New Administration to Make PBM Reform an Immediate Priority in 2025
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
Seniors in Long-Term Care Could Lose Access to Essential LTC Pharmacy Services Absent Action from Congress
A new study from the Senior Care Pharmacy Coalition (SCPC), the nation’s leading voice for long-term care (LTC) pharmacies, performed by CLA (CliftonLarsonAllen LLP) and with input from ATI Advisory details the significant financial impact Medicare drug price negotiations will have on LTC pharmacies that provide essential, government required services to more than two million seniors and others in long-term care.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.